When.com Web Search

  1. Ads

    related to: 5 azacitidine mechanism of action in leukemia treatment

Search results

  1. Results From The WOW.Com Content Network
  2. Azacitidine - Wikipedia

    en.wikipedia.org/wiki/Azacitidine

    Azacitidine, sold under the brand name Vidaza among others, is a medication used for the treatment of myelodysplastic syndrome, myeloid leukemia, [5] [6] and juvenile myelomonocytic leukemia. [ 4 ] [ 9 ] It is a chemical analog of cytidine , a nucleoside in DNA and RNA .

  3. Venetoclax - Wikipedia

    en.wikipedia.org/wiki/Venetoclax

    Venetoclax is also indicated as part of a combination therapy for acute myeloid leukemia (AML). [7] For this purpose it is used with azacitidine, decitabine, or low-dose cytarabine for newly diagnosed adults who are age 75 years or older, or those with other health problems where intensive chemotherapy cannot be used.

  4. Demethylating agent - Wikipedia

    en.wikipedia.org/wiki/Demethylating_agent

    Cytidine analogs such as 5-azacytidine (azacitidine) and 5-azadeoxycytidine are the most commonly used demethylating agents. They work by inhibiting DNA methyltransferases. [1] Both compounds have been approved in the treatment of myelodysplastic syndrome (MDS) by Food and Drug Administration (FDA) in United States.

  5. Decitabine - Wikipedia

    en.wikipedia.org/wiki/Decitabine

    Decitabine (i.e., 5-aza-2′-deoxycytidine), sold under the brand name Dacogen among others, acts as a nucleic acid synthesis inhibitor. [4] It is a medication for the treatment of myelodysplastic syndromes, a class of conditions where certain blood cells are dysfunctional, and for acute myeloid leukemia (AML). [5] Chemically, it is a cytidine ...

  6. Hypomethylating agent - Wikipedia

    en.wikipedia.org/wiki/Hypomethylating_agent

    A hypomethylating agent (or demethylating agent [1]) is a drug that inhibits DNA methylation: the modification of DNA nucleotides by addition of a methyl group.Because DNA methylation affects cellular function through successive generations of cells without changing the underlying DNA sequence, treatment with a hypomethylating agent is considered a type of epigenetic therapy.

  7. List of antineoplastic agents - Wikipedia

    en.wikipedia.org/wiki/List_of_antineoplastic_agents

    Malignant melanoma of the extremities, multiple myeloma, conditioning treatment before haemopoietic stem cell transplant. Myelosuppression, pulmonary fibrosis and pneumonitis (uncommon), skin necrosis (uncommon), anaphylaxis, hepatic sinusoidal obstruction syndrome and SIADH. Secondary malignancies. [16] Streptozotocin: IV, PO: Alkylates DNA.

  1. Ads

    related to: 5 azacitidine mechanism of action in leukemia treatment